Key Insights

Highlights

Treatment Research

2 treatments under study, led by Modified Valsalva Maneuver Revert Protocol

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07617077Not ApplicableRecruiting

NASVAL-SVT: Nasal Swab Versus Modified Valsalva for Supraventricular Tachycardia

Showing all 1 trials

Research Network

Common Treatments

  • Modified Valsalva Maneuver Revert Protocol1
  • Nasopharyngeal Swab Insertion1

Active Sponsors

  • Marmara University Pendik Training and Research Hospital1

Related Conditions

  • Atrioventricular Nodal Reentry Tachycardia1
  • Paroxysmal Supraventricular Tachycardia1
  • Supraventricular Tachycardia1

Activity Timeline